Navigation Links
New Methods to Quit Smoking

One systematic review shows how nicotine patches can double the odds of successful quitting. Another concludes that the antidepressants bupropion and nortriptyline aid long-term smoking cessation, but selective serotonin reuptake inhibitors (e.g. fluoxetine) do not.

Yet another revealed that varenicline (recently approved in the UK by NICE), increased the odds of successful long-term smoking cessation more than threefold compared with pharmacologically unassisted quit attempts.

Ever since Sir Richard Doll and others used careful analysis to show that smoking was a key cause of cancer, there has been pressure to find ways of reducing dependency on tobacco. Richard Dolls work also showed the importance of putting critical analysis and high quality research at the heart of good decision making.

With changes in the law providing fresh impetus for smokers to quit, the catalogue of reviews in The Cochrane Library is a great source of the knowledge needed by people wanting to make well informed decisions. The reviews provide reliable evidence on the strengths and weaknesses of many different types of therapy.

They should help guide policy-makers who are looking for ways to increase the chances that people who want to stop smoking succeed in putting their cigarettes down for good, says Director of the UK Cochrane Centre, Professor Mike Clarke from the University of Oxford.


'"/>




Page: 1

Related medicine news :

1. Methods to have a flat stomach
2. Easier Methods Required to Screen Insulin Resistance
3. Easier Methods Required to Screen Insulin Resistance
4. Accuracy of Some Natural Family Planning Methods Questioned .
5. Adopting Easier Methods To Screen Insulin Resistance
6. US Thinks About The Alternative Methods To Combat Bird Flu
7. Researchers Opts For Better Screening Methods For Detecting Ovarian Cancer
8. Researchers Have Found New Methods To Treat Parkinson’s Diseas
9. Novel Methods To Treat Food Poisoning
10. Medical Center to Test Methods of Improving Cardiac Arrest, Trauma Survival
11. Contraceptive Methods Not Effective Enough
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Methods Quit Smoking

Other Medicine News:Health News:Eye Surgery Errors Rare But Serious 2Health News:Wal-Mart Foundation Announces $1 Million Grant to the Meharry Medical College Center for Women's Health Research 2Health News:Wal-Mart Foundation Announces $1 Million Grant to the Meharry Medical College Center for Women's Health Research 3Health News:Wal-Mart Foundation Announces $1 Million Grant to the Meharry Medical College Center for Women's Health Research 4Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 2Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 3Health News:Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers 4Health News:AMA Commends Aetna for Quality First Commitment 2Health News:Telomerase enzyme structure provides significant new target for anti-cancer therapies 2Health News:Telomerase enzyme structure provides significant new target for anti-cancer therapies 3Health News:Higher-risk kidneys may help solve organ shortage facing older adults 2Health News:Higher-risk kidneys may help solve organ shortage facing older adults 3
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 1B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 2B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 3B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 4The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 1The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 2The Wellness Community Launches National Education Program Addressing the Cost of Cancer Care 49748 3Pennsylvania Department of Health Receives Recovery Funds for New Healthy Homes Program 49746 1Pennsylvania Department of Health Receives Recovery Funds for New Healthy Homes Program 49746 2